Growing at an Unbelievable Rate: Corcept Therapeutics Inc (CORT) Stock
Truist raised the price target for the Corcept Therapeutics Inc (NASDAQ:CORT) stock from “a Hold” to “a Buy”. The rating was released on November 06, 2023, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $27. The stock was downgraded by Jefferies, who […]
Earnings and valuation of Beam Therapeutics Inc (BEAM) Stock are impressive
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Are Options A Good Investment Right Now? Novavax, Inc. (NVAX) Stock
B. Riley Securities raised the price target for the Novavax, Inc. (NASDAQ:NVAX) stock from “a Neutral” to “a Buy”. The rating was released on August 09, 2023, according to finviz. We previously noted in another research note published on April 20, 2023 by TD Cowen that downgraded the stock from an Outperform to a Market […]
A fresh round of sideways trading continues for Vistra Corp (VST) Stock.
Janney raised the price target for the Vistra Corp (NYSE:VST) stock to “a Buy”. The rating was released on April 18, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on July 09, 2021, from Neutral to Buy and set the price objective to $23. In their […]
Will Earnings Beat Estimates? Tandem Diabetes Care Inc (TNDM) Stock
Wells Fargo raised the price target for the Tandem Diabetes Care Inc (NASDAQ:TNDM) stock from “an Equal weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. We previously noted in another research note published on April 25, 2024 by Leerink Partners that upgraded the stock from a Market perform […]
Maravai LifeSciences Holdings Inc (MRVI) Stock: Amazing technical data that you never knew existed
Craig Hallum raised the price target for the Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) stock to “a Buy”. The rating was released on April 10, 2024, according to finviz. We previously noted in another research note published on December 12, 2023 by BofA Securities that upgraded the stock from a Neutral to a Buy with a […]
Does Anywhere Real Estate Inc (HOUS) Stock Really Excited You?
JP Morgan raised the price target for the Anywhere Real Estate Inc (NYSE:HOUS) stock from “a Neutral” to “an Underweight”. The rating was released on December 18, 2023, according to finviz. The research report from Keefe Bruyette has downgraded the stock from Outperform to Mkt Perform, with a price target set at $7. The stock […]
Where are Investors’ Sentiments? Lithium Americas Corp (NewCo) (LAC) Stock
Scotiabank lowered the price target for the Lithium Americas Corp (NewCo) (NYSE:LAC) stock from “a Sector outperform” to “a Sector perform”. The rating was released on March 18, 2024, according to finviz. In their research brief published October 18, 2023, Deutsche Bank analysts downgraded the Lithium Americas Corp (NewCo) stock from Buy to Hold with […]
The Underside Of Viking Therapeutics Inc (VKTX) Stock Is A Little Uncertain
Oppenheimer raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Oppenheimer has reiterated the stock to Outperform, with a price target set at $116. The stock was resumed by ROTH MKM, who disclosed in a […]
Would Dyne Therapeutics Inc (DYN) Stock like to attract the attention of traders?
Morgan Stanley raised the price target for the Dyne Therapeutics Inc (NASDAQ:DYN) stock to “an Overweight”. The rating was released on April 30, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $27. The stock was initiated by Oppenheimer, […]
